We Are Pink for a Purpose During Breast Cancer Awareness Month
This October, we stand united in our commitment to improve the lives of patients battling breast cancer. It’s our promise to provide personalized services, clinical expertise, and the compassionate care every woman deserves throughout their journey.
Our Purpose
Currently, our breast cancer patients’
average copay is $13
Industry leading time to first fill (TTFF)
of 3.9 days
Commitment to quality and service
with a best-in-class
patient satisfaction score (NPS) of 98*
Our Commitment
- As a specialty pharmacy 100% focused on cancer, we will act as your advocate with your physician, insurance company, and others involved in your treatment.
- Timing is crucial when it comes to cancer treatment. Our goal, without prior authorization or funding issues, is to have your medication delivered within 3-4 days. We even provide complimentary overnight shipping to your doorstep.
- Our OncoAdvocate® Team explores funding options for qualified patients quickly with our proprietary Funding FastTrack program.
- We will make sure you understand your medications, their dosage, and any potential side effects. Our clinicians are on call 24/7 if you have any questions at 877.662.6633.
Onco360 Dispenses these Common Breast Cancer Medications**
Abraxane® (nab-paclitaxel)
Adriamycin® (doxorubicin)
Adrucil® (fluorouracil)
Afinitor® (everolimus)
Arimidex® (anastrozole)
Aromasin® (exemestane)
Arimidex® (anastrozole)
Cytoxan® (cyclophosphamide)
Doxil® (liposomal doxorubicin)
Ellence® (epirubicin)
Enhertu® (fam-trastuzumab deruxtecan)
Faslodex® (fulvestrant)
Femara® (letrozole)
Gemzar® (gemcitabine)
Halaven® (eribulin)
Herceptin® (trastuzumab)
Herceptin Hylecta™ (trastuzumab, hyaluronidase)
Herzuma® (trastuzumab biosimilar)
Ibrance® (palbociclib)
Inluriyo™ (imlunestrant)
Itovebi™ (inavolisib)
Ixempra® (ixabepilone)
Jemperli (dostarlimab)
Kadcyla® (ado-trastuzumab emtansine)
Kanjinti® (trastuzumab biosimilar)
Keytruda® (pembrolizumab)
Kisqali® (ribociclib)
Margenza® (margetuximab)
Megace® (megestrol acetate)
Navelbine® (vinorelbine)
Nerlynx® (neratinib)
Nolvadex® (tamoxifen)
Ogivri® (trastuzumab biosimilar)
Ontruzant® (trastuzumab biosimilar)
Orserdu® (elacestrant)
Paraplatin® (carboplatin)
Perjeta® (pertuzumab)
Phesgo® (pertuzumab/trastuzumab, hyaluronidase)
Platinol® (cisplatin)
Retevmo® (selpercatinib)
Rozlytrek® (entrectinib)
Soltamox® (tamoxifen)
Talzenna® (talazoparib)
Taxol® (paclitaxel)
Taxotere® (docetaxel)
Trazimera® (trastuzumab biosimilar)
Trexall® (methotrexate)
Truqap® (capivasertib)
Tukysa® (tucatinib)
Tykerb® (lapatinib)
Verzenio® (abemaciclib)
Xeloda® (capecitabine)
Zoladex® (goserelin)
**This list is a small portion of the comprehensive medications Onco360 can provide.
Partnering with a Purpose
For the second year in a row, we’ve donated to NBCF’s National Mammography Program and helped provide more than 180 mammograms to women in need.
Helpful Resources:
National Breast Cancer Foundation
Living Beyond Breast Cancer
Breastcancer.org
If you are a provider and would like to refer to Onco360, click below
HOW TO REFER
*Third-party survey data provided by MMIT. Report date Q4 2024. MMITnetwork.com